Michael J. Carson

CIK: 0001896079

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NVCT

Nuvectis Pharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

NVCT
Nuvectis Pharma, Inc.
Aug 3, 2026
Award(A)
Direct
30K shares-
NVCT
Nuvectis Pharma, Inc.
Jan 6, 2026
Award(A)
Direct
61.2K shares-
NVCT
Nuvectis Pharma, Inc.
Jan 2, 2025
Award(A)
Direct
51K shares-
NVCT
Nuvectis Pharma, Inc.
Nov 7, 2024
Sale(S)
Direct
2.8K shares at avg. $8.16$22K
NVCT
Nuvectis Pharma, Inc.
Jan 4, 2024
Award(A)
Direct
34.6K shares-
NVCT
Nuvectis Pharma, Inc.
Jan 3, 2023
Award(A)
Direct
28.8K shares-

		Type	Shares	Price		Ownership
Aug 3, 2026	NVCT Nuvectis Pharma, Inc.	Award(A)	30,000	-	$0	Direct
Jan 6, 2026	NVCT Nuvectis Pharma, Inc.	Award(A)	61,200	-	$0	Direct
Jan 2, 2025	NVCT Nuvectis Pharma, Inc.	Award(A)	51,000	-	$0	Direct
Nov 7, 2024	NVCT Nuvectis Pharma, Inc.	Sale(S)	2,755	$8.16	$22,478	Direct
Jan 4, 2024	NVCT Nuvectis Pharma, Inc.	Award(A)	34,567	-	$0	Direct
Jan 3, 2023	NVCT Nuvectis Pharma, Inc.	Award(A)	28,806	-	$0	Direct

1-6 of 6 transactions

About Carson Michael J.

Carson Michael J. (SEC CIK 0001896079) files insider reports with the SEC as Vice President, Finance of Nuvectis Pharma, Inc. (NVCT).

Signal8 holds 4 ownership filings by Carson Michael J., all Form 4s, filed between Nov 8, 2024 and Aug 5, 2026. Those filings report 6 transactions, from Jan 3, 2023 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Carson Michael J.'s filings is in FORT LEE, NJ.

Recent filings by Carson Michael J.

Aug 3, 2026: Grant or award of NVCT shares (Form 4, code A).
Jan 6, 2026: Grant or award of NVCT shares (Form 4, code A).
Jan 2, 2025: Grant or award of NVCT shares (Form 4, code A).
Nov 7, 2024: Open-market sale of NVCT shares (Form 4, code S).
Jan 4, 2024: Grant or award of NVCT shares (Form 4, code A).

Other insiders filing for Nuvectis Pharma, Inc. (NVCT)

Mosseri Marlio Charles, 10% Owner
BENTSUR RON, Chairman & CEO
Hoberman Kenneth, Director
Oliviero James F III, Director
Sanchez Juan, Director
Kaplan Matthew L., Director

How to read Form 4 transaction codes